In support of this premise, recent studies have demonstrated that the TLR2/MyD88/miRNA155/Ets-1 pathway is required for the production of autoantibodies that form DNA-containing immune complexes [112] and that increased TLR2 expression promotes IL-17 production in SLE patients [117]. The gene discussed is TLR2; the disease is systemic lupus erythematosus.